LivaNova PLC Ordinary Shares (LIVN) is a publicly traded Healthcare sector company. As of May 21, 2026, LIVN trades at $73.85 with a market cap of $3.97B and a P/E ratio of -16.53. LIVN moved +1.08% today. Year to date, LIVN is +16.57%; over the trailing twelve months it is +64.24%. Its 52-week range spans $32.48 to $74.32. Analyst consensus is buy with an average price target of $80.00. Rallies surfaces LIVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LIVN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LIVN recently traded at $73.85. Market cap is $3.97B. P/E ratio is -16.53. Revenue is $1.39B.
| Metric | Value |
|---|---|
| Price | $73.85 |
| Market Cap | $3.97B |
| P/E Ratio | -16.53 |
| EPS | $-4.45 |
| Dividend Yield | 0.00% |
| 52-Week High | $74.32 |
| 52-Week Low | $32.48 |
| Volume | 254 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.39B |
| Net Income | $-242.47M |
| Gross Margin | 67.71% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.39B | $-242.47M | $-4.45 |
| 2024 | $1.25B | $63.23M | $1.17 |
| 2023 | $1.15B | $17.55M | $0.33 |
| 2022 | $1.02B | $-86.25M | $-1.61 |
7 analysts cover LIVN: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $80.00.